Skip to main content
Premium Trial:

Request an Annual Quote

Roche Certifies ImaGenes for CGH Service

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ImaGenes has received certification from Roche NimbleGen to provide services using the firm's comparative genomic hybridization array workflow from its headquarters in Berlin, Roche said today.

Roche noted that over the past six months ImaGenes has also been certified to offer its DNA methylation analysis and its ChIP-chip services, and that it is the first certified CGH provider in Europe.

As a Roche Certified Service Provider, ImaGenes now will offer CGH services using NimbleGen's MS 200 Microarray Scanner, as well as Roche's arrays, reagents, and software.

The CGH service enables the detection of chromosomal abnormalities, copy number variations, and specific break-points at high resolution.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.